Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000182389 | SCV000234726 | pathogenic | not provided | 2013-10-03 | criteria provided, single submitter | clinical testing | The c.859delG mutation has been reported previously in a female patient diagnosed with cardiomyopathy at age 36 and limb-girdle muscular dystrophy at age 37 (Benedetti S et al., 2007; referred to as c.855delG). This mutation causes a shift in reading frame starting at codon Alanine 287, changing it to a Leucine, and creating a premature stop codon at position 193 of the new reading frame, denoted p.Ala287LeufsX193. This mutation is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift mutations in the LMNA gene have been reported in association with DCM. In summary, c.859delG in the LMNA gene is interpreted as a disease-causing mutation. |
Blueprint Genetics | RCV000208368 | SCV000264010 | likely pathogenic | Primary dilated cardiomyopathy | 2015-01-08 | criteria provided, single submitter | clinical testing | |
Epithelial Biology; Institute of Medical Biology, |
RCV000182389 | SCV000088588 | not provided | not provided | no assertion provided | not provided |